Law ❯ Litigation ❯ Securities Law ❯ Shareholder Rights

Class Action

Plaintiff Firms Step Up uniQure Solicitation After FDA Rebuke, With April 13 Lead-Plaintiff Deadline

Investor solicitations intensify following an FDA official’s public dispute of uniQure’s trial design.

Navan Faces Securities Class Action Over IPO Disclosures as Lead-Plaintiff Push Builds

Apollo Investors Get Chance to Lead Securities Class Action Over Epstein Claims

Gartner Securities Class Action Spurs Race for Lead Plaintiff Before May 18

Navan Faces IPO Lawsuits as Investor Firms Mobilize Ahead of April 24 Lead‑Plaintiff Deadline

Investor Lawsuits Target Navan’s IPO Disclosures With Lead-Plaintiff Deadline on April 24

Klarna IPO Investors Face Feb. 20 Deadline to Seek Lead Role in E.D.N.Y. Securities Case

Sprouts Securities Lawsuits Hit Lead-Plaintiff Deadline

Fermi Faces Flurry of Securities Class Actions as Firms Vie for Lead Plaintiff Roles

StubHub Investors Face Jan. 23 Lead-Plaintiff Deadline in IPO Disclosure Lawsuits

Law Firms Court Gauzy Investors for Lead Role in Securities Suit as Feb. 6 Deadline Nears

Investor Firms Step Up Bid to Lead CarMax Securities Case as Jan. 2 Deadline Looms

Law Firms Seek Sprouts Investors to Lead Securities Class Action After October Stock Slide

CarMax Securities Suit Enters Lead-Plaintiff Phase as Jan. 2 Deadline Nears

Gauzy Investors Face Feb. 6 Deadline in Securities Class Action Over French Insolvency Disclosure

DexCom Investor Suits Intensify as Firms Set Competing Lead-Plaintiff Deadlines

Inspire Medical Investors Get Jan. 5 Deadline Reminder in Securities Suit Over Inspire V Rollout

Freeport-McMoRan Investors Urged to Seek Lead Role in Grasberg Safety Class Action

Marex and CarMax Securities Suits Enter Lead‑Plaintiff Phase With New Deadlines

Inspire Medical Investors Press Class Action Over Inspire V Rollout With Lead-Plaintiff Deadline Jan. 5